Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Sponsor: Biocells Medical
Summary
This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.
Official title: Phase II Randomized Controlled Trial Evaluating Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Key Details
Gender
All
Age Range
48 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-11-23
Completion Date
2029-11-23
Last Updated
2026-03-13
Healthy Volunteers
No
Interventions
Intrathecal (IT)
Intrathecal injection of 3 ml between L4-L5
Intravenous
Intravenous injection via a drip
Locations (1)
Neuropostep
Warsaw, Poland